The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic ...

Teva stock retreated Wednesday after the pharmaceutical company reported a drop in fourth-quarter revenue.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...